A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews
Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - Sahm
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - Sahm
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus
Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech
Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
Agilent Technologies (A) Declares $0.255 Quarterly Dividend; 0.8% Yield - StreetInsider
Agilent Announces Cash Dividend of 25.5 Cents per Share - Business Wire
Agilent Announces Cash Dividend of 25.5 Cents per Share - Business Wire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page